Stocksigma LogoStocksigma Logo

Alembic Pharmaceuticals Schedules Board Meeting to Approve Q2 and H1 FY27 Results

Alembic Pharmaceuticals Limited announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the unaudited financial results for

Alembic Pharmaceuticals Schedules Board Meeting to Approve Q2 and H1 FY27 Results

Alembic Pharmaceuticals Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

Alembic Pharmaceuticals Schedules Board Meeting to Approve Q2 and H1 FY27 Results Alembic Pharmaceuticals Limited announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with the company's insider trading code of conduct, the trading window for dealing in company securities, which closed on 1st Oct'26, will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Alembic Pharmaceuticals Ltd

All Alembic Pharmaceuticals Ltd announcements